Updated on 27 June 2014
The report also said the health ministry must adopt "a reasoned and hardened position" vis-à-vis the apex court to let the executive function.
According to a senior official, around 200 applications seeking permission to conduct clinical trials are pending with the regulator. Officials pointed out that earlier, an approval used to take 12-16 weeks, whereas now there are no clear timelines for a regulatory clearance. This is directly impacting the growth of pharmaceutical companies as well as clinical research organisations.
In the past year, the Rs 80,000 crore domestic pharmaceutical sector has witnessed a significant decline in growth.